Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategy

被引：1

作者：

Zhao, Wen-Yi ^{[1
]}

Zhuang, Chun ^{[1
]}

Xu, Jia ^{[1
]}

Wang, Ming ^{[1
]}

Zhang, Zi-Zhen ^{[1
]}

Tu, Lin ^{[1
]}

Wang, Chao-Jie ^{[1
]}

Ling, Tian-Long ^{[1
]}

Cao, Hui ^{[1
]}

Zhang, Zhi-Gang ^{[2
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200127, Peoples R China

来源：

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2014年 / 6卷 / 06期

基金：

中国国家自然科学基金;

关键词：

Gastrointestinal stromal tumor; somatostatin receptor; octreotide; pasireotide; prognosis; NEUROENDOCRINE TUMORS; ADJUVANT IMATINIB; ANALOGS; CELLS; RISK; INHIBITION; ACTIVATION; EFFICACY; GISTS; SSTR2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Somatostatin receptors (SSTRs) already act as important roles in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) with high expression levels for prognosis predicting and octreotide LAR treatment purposes but less noticed in gastrointestinal stromal tumors (GISTs). Our study aims to fully evaluate the expression levels and prognostic values of SSTRs in GIST patients. For SSTRs expression detection, qPCR were used in 25 fresh GIST specimens, and then, 453 GIST samples (405 GISTs with operation only and 48 with imatinib adjuvant therapy after surgery) were collected for tissue microarrays (TMAs) construction and confirmed by immunohistochemistry (IHC). Clinicopathological data were confirmed by pathological diagnosis and clinical recorders, recurrence-free survivals (RFS) were evaluated in 453 GIST patients. With IHC performed, SSTR1 and SSTR2 present high positive proportion (81.9% and 87.6%) in 453 GISTs in our study, and positive expression rates of SSTR3, SSTR4 and SSTR5 are 56.1%, 8.8% and 47.2%, respectively. SSTR2 and SSTR5 negative expression are associated with decreased RFS when compared to positive cases by Kaplan-Meier survival analyses with log-rank test and univariate analysis in GISTs, furthermore, SSTR2 was an independent prognostic indicator for GISTs by multivariate analysis. In our study, detection of SSRT2 and SSTR5 expression helps to predict different prognosis in GIST patients. SSTR2 is a novel independent prognostic biomarker for GISTs. With high expression performance of SSTRs in GISTs, new therapeutic strategies such as octreotide or pasireotide LAR could be taken into consideration in selected advanced GIST patients.

引用

页码：831 / 840

页数：10

共 25 条

[1] Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs [J].

Arne, Gabriella ;

Nilsson, Bengt ;

Dalmo, Johanna ;

Kristiansson, Erik ;

Arvidsson, Yvonne ;

Forssell-Aronsson, Eva ;

Nilsson, Ola ;

Ahlman, Hakan .

ACTA ONCOLOGICA, 2013, 52 (04) :783-792

[2] Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives [J].

Baldelli, Roberto ;

Barnabei, A. ;

Rizza, L. ;

Isidori, A. M. ;

Rota, F. ;

Di Giacinto, P. ;

Paoloni, A. ;

Torino, F. ;

Corsello, S. M. ;

Lenzi, A. ;

Appetecchia, M. .

FRONTIERS IN ENDOCRINOLOGY, 2014, 5

[3] INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 IS MEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS [J].

BUSCAIL, L ;

ESTEVE, JP ;

SAINTLAURENT, N ;

BERTRAND, V ;

REISINE, T ;

OCARROLL, AM ;

BELL, GI ;

SCHALLY, AV ;

VAYSSE, N ;

SUSINI, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1580-1584

[4] The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells [J].

Cerovac, Vesna ;

Monteserin-Garcia, Jose ;

Rubinfeld, Hadara ;

Buchfelder, Michael ;

Losa, Marco ;

Florio, Tullio ;

Paez-Pereda, Marcelo ;

Stalla, Guenter K. ;

Theodoropoulou, Marily .

CANCER RESEARCH, 2010, 70 (02) :666-674

[5] Gastrointestinal stromal tumours: origin and molecular oncology [J].

Corless, Christopher L. ;

Barnett, Christine M. ;

Heinrich, Michael C. .

NATURE REVIEWS CANCER, 2011, 11 (12) :865-878

[6] Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].

DeMatteo, Ronald P. ;

Ballman, Karla V. ;

Antonescu, Cristina R. ;

Maki, Robert G. ;

Pisters, Peter W. T. ;

Demetri, George D. ;

Blackstein, Martin E. ;

Blanke, Charles D. ;

von Mehren, Margaret ;

Brennan, Murray F. ;

Patel, Shreyaskumar ;

McCarter, Martin D. ;

Polikoff, Jonathan A. ;

Tan, Benjamin R. ;

Owzar, Kouros .

LANCET, 2009, 373 (9669) :1097-1104

[7] Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[8] ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour [J].

Edris, Badreddin ;

Espinosa, Inigo ;

Muehlenberg, Thomas ;

Mikels, Amanda ;

Lee, Cheng-Han ;

Steigen, Sonja E. ;

Zhu, Shirley ;

Montgomery, Kelli D. ;

Lazar, Alexander J. F. ;

Lev, Dina ;

Fletcher, Jonathan A. ;

Beck, Andrew H. ;

West, Robert B. ;

Nusse, Roel ;

van de Rijn, Matt .

JOURNAL OF PATHOLOGY, 2012, 227 (02) :223-233

[9] Risk stratification of patients diagnosed with gastrointestinal stromal tumor [J].

Joensuu, Heikki .

HUMAN PATHOLOGY, 2008, 39 (10) :1411-1419

[10] Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour Considerations for Optimal Management [J].

Joensuu, Heikki .

DRUGS, 2012, 72 (15) :1953-1963

← 1 2 3 →